4/A

PRIMARY DOCUMENT

Company: FILANA THERAPEUTICS, INC.
Filed: May 30, 2012
Period of Report: May 17, 2012
Accession Number: 0001245261-12-000007

View Document ↗ View on SEC.gov ↗